Navigation Links
WATCHMAN® Receives German Reimbursement Coverage
Date:10/1/2010

MINNEAPOLIS, Oct. 1 /PRNewswire/ -- Atritech announces German reimbursement coverage of the left atrial appendage closure procedure in 2011.  The 2011 G-DRG (German Diagnosis Related Group) Catalog recently published on the InEK website (www.g-drg.de) adds left atrial appendage closure procedure to an existing G-DRG code.

Atritech's WATCHMAN Left Atrial Appendage Closure Technology is a device alternative to long term warfarin therapy in patients with atrial fibrillation.  The WATCHMAN is the only LAA closure device that has been studied under a multi-center, prospective randomized clinical study (PROTECT AF). Initial results of the PROTECT AF clinical study were published in the Lancet in August, 2009.   The most recent data presented at the TCT meeting in Washington DC, continues to demonstrate a relative risk reduction of 30% for all stroke, cardiovascular death and systemic embolism compared to long term warfarin therapy.  

"The favorable reimbursement decision in Germany along with the recent National Institute for Health and Clinical Excellence (NICE) published guidelines on LAA Closure in the U.K., further validate the clinical and economic viability of LAA closure.  As our data continues to demonstrate a reduction in stroke risk and improved safety results, we expect favorable reimbursement decisions in other major markets looking to reduce the economic burden of stroke," says Jim Bullock, President & CEO Atritech.

About Atritech

Atritech is a privately held company based in Plymouth, Minnesota.  Major investors in Atritech include Split Rock Partners, Thomas, McNerney and Partners, Prism Venture Partners, Tullis-Dickerson, The Vector Group, Thoma Cressey Funds, The Rahn Group, SightLine Partners and Affinity Capital. For more information, visit www.atritech.net.


'/>"/>
SOURCE Atritech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Lingohocken Fire Company Receives PAD Donation After Recent Rescue at Fox Heath Farm
2. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
3. Advanced Life Sciences Receives $1.5 Million From Exercise of Unit Warrants and Secures Financing Commitment
4. China Shenghuo Receives Notice from NYSE Amex LLC Regarding Listing Standards
5. Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene
6. Hospira Receives TGA Approval for Nivestim™, Australias First Biosimilar Filgrastim
7. Hologics Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
8. Microfluidic Systems (MFSI) Receives Award from Inc. Magazine
9. Netsmart Technologies InfoScriber™ e-Prescribing Service Receives Additional Surescripts® Certifications
10. Angel Medical Systems Receives CE Mark Approval for the AngelMed Guardian, an Implantable Device Designed to Provide Early Warning of a Heart Attack
11. Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology:
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards luncheon ... editorial and design excellence across a range of sectors. This year’s program included the ...
Breaking Medicine News(10 mins):